MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,041,000 | +52.7% | 33,846 | +16.4% | 0.00% | +50.0% |
| Q1 2016 | $1,337,000 | -3.7% | 29,071 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $1,389,000 | +13.7% | 28,739 | -0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,222,000 | -45.0% | 28,747 | +47.7% | 0.00% | -33.3% |
| Q2 2015 | $2,223,000 | +68.2% | 19,468 | +90.1% | 0.00% | +50.0% |
| Q1 2015 | $1,322,000 | -77.0% | 10,243 | -82.2% | 0.00% | -77.8% |
| Q4 2014 | $5,740,000 | +35.9% | 57,631 | +35.0% | 0.01% | +28.6% |
| Q3 2014 | $4,223,000 | +22.7% | 42,703 | -4.3% | 0.01% | +16.7% |
| Q2 2014 | $3,441,000 | +3.0% | 44,638 | -14.0% | 0.01% | 0.0% |
| Q1 2014 | $3,340,000 | +21.4% | 51,890 | +20.3% | 0.01% | +20.0% |
| Q4 2013 | $2,752,000 | -5.9% | 43,127 | -11.6% | 0.01% | -16.7% |
| Q3 2013 | $2,925,000 | +21.8% | 48,800 | 0.0% | 0.01% | +20.0% |
| Q2 2013 | $2,401,000 | – | 48,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |